ARCHIVES

St. John’s Wort Not Indicated For Patients On Irinotecan

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

ACCC Recommends Cancer Act Changes

August 27, 1976

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Analysis Finds Exercise Lowers Colon Cancer Risk

February 27, 2009

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013

Also Von Eschenbach’s NCI Farewell Reception, Gift Solicitation, Raises Legal And Ethical Issues.

May 5, 2006